EXABLATE PRIME
LIVE

Serial Number

98273591

Owner

Insightec Ltd.

Attorney

Julia Anne Matheson

First Use Date

Dec 27, 2023

Filing Date

Nov 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EXABLATE PRIME Trademark

Serial Number: 98273591 • Registration: 7788720

EXABLATE PRIME is a trademark filed by Insightec Ltd. on November 16, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Insightec Ltd. (14 trademarks)

5 Nachum Heth Street
Tirat Carmel 3912001 , IL

Entity Type: 03

Trademark Details

Filing Date

November 16, 2023

Registration Date

May 6, 2025

First Use Anywhere

December 27, 2023

First Use in Commerce

December 27, 2023

Published for Opposition

July 30, 2024

Goods & Services

Downloadable software for use in medical screening, diagnostics, and medical therapy, namely, for conducting guided ultrasound; downloadable computer software, namely, for the management and operation of medical ultrasound systems sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes; downloadable software for use in the treatment of neurological, oncological, gynecological, and urological disease by means of guided ultrasound; downloadable computer software for use in the treatment of central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases by means of guided ultrasound sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes

Medical ultrasound apparatus; ultrasound diagnostic apparatus and user manuals sold as a unit therewith; ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier, by itself or in combination with other therapies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 15, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 15, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 15, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 15, 2025 AITU
USE AMENDMENT FILED
Feb 5, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 5, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2023 NWOS
NEW APPLICATION ENTERED
Nov 20, 2023 NWAP